UBS Downgrades Impax Laboratories To Sell

Loading...
Loading...
Analysts at UBS downgraded
Impax Laboratories IncIPXL
from Neutral to Sell. Impax Laboratories shares have gained 99.84 percent over the past 52 weeks, while the S&P 500 index has gained 12.45 percent in the same period. Impax Laboratories' shares declined 3.04 percent to $49.70 in pre-market trading.
Posted In: DowngradesAnalyst RatingsUBS
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...